Yongbo Liu

2.3k total citations · 1 hit paper
74 papers, 1.7k citations indexed

About

Yongbo Liu is a scholar working on Molecular Biology, Toxicology and Epidemiology. According to data from OpenAlex, Yongbo Liu has authored 74 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 12 papers in Toxicology and 12 papers in Epidemiology. Recurrent topics in Yongbo Liu's work include Bioactive Compounds and Antitumor Agents (12 papers), Genomics, phytochemicals, and oxidative stress (11 papers) and Natural product bioactivities and synthesis (8 papers). Yongbo Liu is often cited by papers focused on Bioactive Compounds and Antitumor Agents (12 papers), Genomics, phytochemicals, and oxidative stress (11 papers) and Natural product bioactivities and synthesis (8 papers). Yongbo Liu collaborates with scholars based in China, United States and United Kingdom. Yongbo Liu's co-authors include Subhash C. Gautam, Xiaohua Gao, Dorrah Deeb, Scott A. Dulchavsky, Ali S. Arbab, Hao Jiang, George Divine, Haibing Zhang, Xiaoxia Wu and Xixi Zhang and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Nano Letters.

In The Last Decade

Yongbo Liu

65 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

2022 179 citations Yongbo Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yongbo Liu China	23	1.1k	238	231	226	124	74	1.7k
Goutam Dey India	24	716 0.6×	195 0.8×	148 0.6×	270 1.2×	57 0.5×	46	1.7k
Wuguang Lu China	23	1.1k 1.0×	222 0.9×	279 1.2×	245 1.1×	70 0.6×	54	1.8k
Xingmei Duan China	26	847 0.8×	104 0.4×	235 1.0×	181 0.8×	56 0.5×	56	1.7k
Xuenong Zhang China	29	1.1k 1.0×	176 0.7×	261 1.1×	237 1.0×	71 0.6×	69	2.0k
Peng Zou China	27	1.1k 1.0×	396 1.7×	135 0.6×	180 0.8×	125 1.0×	58	1.8k
Mohsen Rashidi Iran	24	996 0.9×	488 2.1×	153 0.7×	320 1.4×	99 0.8×	96	1.9k
Seung Ho Baek South Korea	22	738 0.7×	216 0.9×	89 0.4×	318 1.4×	110 0.9×	60	1.6k
Dimakatso Alice Senthebane South Africa	12	747 0.7×	290 1.2×	160 0.7×	464 2.1×	53 0.4×	13	1.9k
Jana Jakubı́ková Slovakia	28	1.4k 1.3×	174 0.7×	224 1.0×	554 2.5×	144 1.2×	78	2.2k
Wen‐Sheng Wu Taiwan	22	1.0k 0.9×	360 1.5×	181 0.8×	273 1.2×	105 0.8×	41	1.8k

Countries citing papers authored by Yongbo Liu

Since Specialization

Citations

This map shows the geographic impact of Yongbo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongbo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongbo Liu more than expected).

Fields of papers citing papers by Yongbo Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongbo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongbo Liu. The network helps show where Yongbo Liu may publish in the future.

Co-authorship network of co-authors of Yongbo Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongbo Liu. A scholar is included among the top collaborators of Yongbo Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongbo Liu. Yongbo Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yongbo, et al.. (2025). ZKSCAN5 transcriptional regulation of APOC1 modulates ferroptosis via PI3K/AKT/SREBP2/SLC1A5 axis. Journal of Translational Medicine. 23(1). 1020–1020.

Wang, Zhen, Qi Li, Yongbo Liu, et al.. (2025). Lumpy skin disease virus ORF142 suppresses the cGAS/STING-mediated IFN-I pathway through NBR1-mediated STING autophagic degradation. Microbial Pathogenesis. 208. 107959–107959. 1 indexed citations

Liu, Yuan, Qi Pan, Tao Zhou, et al.. (2025). Development of a Survival Predictive Model After Pediatric Liver Transplantation: A Single-center Retrospective Cohort Study. Transplantation. 109(8). e400–e408.

Xiao, Kai, Madi Sun, Yongbo Liu, et al.. (2024). Hepatic‐Accumulated Obeticholic Acid and Atorvastatin Self‐Assembled Nanocrystals Potentiate Ameliorative Effects in Treatment of Metabolic‐Associated Fatty Liver Disease. Advanced Science. 11(10). e2308866–e2308866. 13 indexed citations

Miao, Shan, Yongbo Liu, Gaoyang Wang, et al.. (2024). tRNA m1A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8+ T cells. The Journal of Experimental Medicine. 222(3). 9 indexed citations

Wang, Yong, Bingyi Chen, Yongbo Liu, et al.. (2023). ABIN1 (Q478) is Required to Prevent Hematopoietic Deficiencies through Regulating Type I IFNs Expression. Advanced Science. 11(3). e2303555–e2303555. 2 indexed citations

Liu, Yongbo, Xu Zhao, Zhengmin Zhang, et al.. (2023). Blowing tough polylactide film enabled by the in situ construction of covalent adaptive networks with epoxidized soybean oil as dynamic crosslinks. Green Chemistry. 25(13). 5182–5194. 16 indexed citations

Li, Chen, Huilong Zhu, Yongkui Zhang, et al.. (2021). First Demonstration of Novel Vertical Gate-All-Around Field-Effect-Transistors Featured by Self-Aligned and Replaced High-κ Metal Gates. Nano Letters. 21(11). 4730–4737. 22 indexed citations

Huang, Weixing, Huilong Zhu, Yongkui Zhang, et al.. (2021). Ferroelectric Vertical Gate-All-Around Field-Effect-Transistors With High Speed, High Density, and Large Memory Window. IEEE Electron Device Letters. 43(1). 25–28. 16 indexed citations

10.

Zhang, Junjie, Yan‐dan Zhou, Yongbo Liu, et al.. (2021). Protective Effect of 20(R)-Ginsenoside Rg3 Against Cisplatin-Induced Renal Toxicity via PI3K/AKT and NF-κB Signaling Pathways Based on the Premise of Ensuring Anticancer Effect. The American Journal of Chinese Medicine. 49(7). 1739–1756. 13 indexed citations

11.

Zhang, Haiwei, Haiwei Zhang, Xixi Zhang, et al.. (2016). A novel sgRNA selection system for CRISPR-Cas9 in mammalian cells. Biochemical and Biophysical Research Communications. 471(4). 528–532. 7 indexed citations

12.

Deeb, Dorrah, et al.. (2016). The inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is associated with the inhibition of Akt/NF-κB/mTOR prosurvival signaling. International Journal of Oncology. 49(3). 1139–1147. 19 indexed citations

13.

Gao, Xiaohua, Yongbo Liu, Dorrah Deeb, Ali S. Arbab, & Subhash C. Gautam. (2014). Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling.. PubMed. 10(4). 275–83. 23 indexed citations

14.

Deeb, Dorrah, Xiaohua Gao, Yongbo Liu, et al.. (2013). Inhibition of Telomerase Activity by Oleanane Triterpenoid CDDO-Me in Pancreatic Cancer Cells is ROS-Dependent. Molecules. 18(3). 3250–3265. 39 indexed citations

15.

Gao, Xiaohua, Dorrah Deeb, Yongbo Liu, et al.. (2011). Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer. Cancers. 3(3). 3353–3369. 28 indexed citations

16.

Gao, Xiaohua, Yongbo Liu, Dorrah Deeb, et al.. (2011). Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-κB/mTOR signaling.. PubMed. 31(11). 3673–81. 24 indexed citations

17.

Liu, Yongbo, Xiaohua Gao, Dorrah Deeb, & Subhash C. Gautam. (2011). Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells. Biochemical and Biophysical Research Communications. 417(1). 570–575. 23 indexed citations

18.

Deeb, Dorrah, Xiaohua Gao, Yongbo Liu, et al.. (2011). Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling. Carcinogenesis. 32(5). 757–764. 34 indexed citations

19.

Gao, Xiaohua, Dorrah Deeb, Hao Jiang, et al.. (2010). Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells.. PubMed. 30(3). 785–92. 27 indexed citations

20.

Gao, Xiaohua, Dorrah Deeb, Yongbo Liu, et al.. (2009). Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-κB. Immunopharmacology and Immunotoxicology. 31(3). 477–484. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact